Catalog No.
RHE09901
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
FCM: 1:20-1:100, WB: 1:1000-1:2000
Target
SSTR5, SS-5-R, SS5R, SS5-R, Somatostatin receptor type 5
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P35346
Applications
FCM, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1U95
Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature., PMID:39842795
Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations., PMID:39202532
Expression of somatostatin receptors in canine and feline meningioma., PMID:39011594
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas., PMID:37444563
Immunohistochemical somatostatin receptor expression in insulinomas., PMID:36680557
Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study., PMID:36362289
Correlation of Somatostatin Receptor 1-5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms., PMID:35008325
Differences in somatostatin receptor subtype expression in patients with acromegaly: new directions for targeted therapy?, PMID:34674191
Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children., PMID:34497584
Cytokeratin 8/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity., PMID:33738859
Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review., PMID:33544787
Evaluation of the expression of somatostatin receptors by immunohistochemistry in neuroendocrine tumors of the small intestine., PMID:32429652
Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex., PMID:31873798
Immunohistochemical Expression of Somatostatin Receptor Subtypes in a Panel of Neuroendocrine Neoplasias., PMID:31381461
Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors., PMID:30657933
Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment., PMID:30531694
Immunohistochemical Analysis of Somatostatin Receptors in Endometriosis Tissue Samples: A Retrospective Study., PMID:29750706
Expression of growth hormone gene in the baboon eye., PMID:29407222
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets., PMID:29282035
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs., PMID:29180250
Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues., PMID:28396686
A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas., PMID:28384628
Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining., PMID:28182792
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours., PMID:27875519
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin., PMID:27544389
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors., PMID:26673010
Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines., PMID:25925002
Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity., PMID:25765179
Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas., PMID:25554089
Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers., PMID:25494861
Expression and localization of somatostatin receptor types 3, 4 and 5 in the wild-type, SSTR1 and SSTR1/SSTR2 knockout mouse cochlea., PMID:25149275
Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide., PMID:25008035
Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma., PMID:24634938
Somatostatin receptors type 2 and 5 expression and localization during human pituitary development., PMID:24189142
Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies., PMID:24182563
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide., PMID:24092823
Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor., PMID:23418396
Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors., PMID:23236542
Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer., PMID:22996996
Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors., PMID:22558472
Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study., PMID:22419713
Distribution of somatostatin receptor 5 in mouse and bullfrog retinas., PMID:22244811
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors., PMID:22156600
SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes., PMID:22136833
Immunohistochemical detection of dopamine D2 receptors in neuroendocrine tumours., PMID:22069098
Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4., PMID:21952553
Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct., PMID:21667819
Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours., PMID:21626438
Restricted expression of somatostatin receptor 3 to primary cilia in the pancreatic islets and adenohypophysis of mice., PMID:21383513
Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma., PMID:21298743